| Literature DB >> 33050273 |
Simona Del Ferraro1, Tiziana Falcone1,2, Alberto Ranavolo1, Vincenzo Molinaro1.
Abstract
BACKGROUND: New wearable assistive devices (exoskeletons) have been developed for assisting people during work activity or rehabilitation. Although exoskeletons have been introduced into different occupational fields in an attempt to reduce the risk of work-related musculoskeletal disorders, the effectiveness of their use in workplaces still needs to be investigated. This systematic review focused on the effects of upper-body exoskeletons (UBEs) on human metabolic cost and thermophysiological response during upper-body work tasks.Entities:
Keywords: exoskeletons; lifting task; metabolic cost; occupational health; overhead work; oxygen consumption; thermal comfort; wearable assistive device; work-related musculoskeletal disorders
Mesh:
Year: 2020 PMID: 33050273 PMCID: PMC7600262 DOI: 10.3390/ijerph17207374
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1The flowchart of the study selection process.
Descriptive analysis of the studies considered in the review according to the PICO method.
| Ref. | Population | Intervention (WEC) | Comparison (WOEC) | Outcome | ||||
|---|---|---|---|---|---|---|---|---|
| Author (year) | Subjects Involved in the Study | Task | Exoskeleton Tested | Experimental Setup | Experimental Setup | Metabolic Measured Parameters | Metabolic Results Considered | Other Results Reported |
| Alemi et al. (2020) [ | 18 young subjects | Repetitive lifting | SuitX | Trial: cycle of lifting/lowering a 6.8 kg panel for 5 min; f: 5 lifting/lowering cycles per min. 2 LS: symmetric and asymmetric lifting; 2 posture: standing and kneeling. | Trial: cycle of lifting/lowering a panel for 5 min; 2 LS: symmetric and asymmetric lifting 2 posture: standing and kneeling. |
| EER, | sEMG: |
| Schmalz et al. (2019) [ | 12 healthy subjects | Overhead working | PAEXO | Sequence of sessions G1: WE+B+WOE+B+WE. | Each WOE is a sequence of 2 tasks (T1, T2) of 5 min with a break of 10 min. |
|
| Kinematics: shoulder and elbow angles; |
| Baltrusch et al. | 13 M subjects for WT | Walking, | Laevo HC | WT: 5 min of walking on treadmill with Laevo LC at PWS and PWSX. | WT: 5 min of walking on treadmill at PWS and PWSX. |
|
| Kinematics: |
| Whitfield et al. (2014) [ | 15 M subjects | Repetitive lifting | PLAD | LT: cycle of lifting/lowering a box (average weight 8.9 ± 1.6kg) for 15 min; | LT: cycle of lifting/lowering a 8.9-kg box for 15 min; |
|
| Kinematics: maximum knee flexion angles. |
| Baltrusch et al. (2020) [ | 11 M employees of KLM | Symmetric repetitive lifting | SPEXOR | LT: cycle of lifting/lowering a 10-kg box from ankle height to hip height for 5 min; | LT: cycle of lifting/lowering a 10-kg box from ankle height to hip height for 5 min; |
|
| Kinematics: |
| Wei et al. (2020a) [ | 8 M subjects | Static holding posture | MeBot-EXO | SST: forward trunk flexion at an angle of 50–55 degrees and this stooping position is held for 5 min. | SST: forward trunk flexion at an angle of 50–55 degrees and this stooping position is held for 5 min. |
|
| sEMG: |
| Han et al. (2019) [ | 3 subjects | Repetitive lifting | Passive energy-storing booster exoskeleton | LT: 20 cycles of lifting/lowering a 9-kg object. | ? |
|
| |
| Maurice et al. (2020) [ | 12 M subjects | Overhead | PAEXO | Overhead pointing task: moving the power drill as far as possible from a starting point to a target and remain on the target for 2 s. | Overhead pointing task: moving the power drill as far as possible from a starting point to a target and remain on the target for 2 s. |
|
| sEMG: |
| Wei et al. (2020b) [ | 7 M for the sEMG measurement. | Repetitive semi-squat lifting | MeBot-EXO | LT: carrying an 8 kg weight from the ground back and forward to a platform at a height 0.5 m for 5 min. | LT: carrying an 8 kg weight from the ground back and forward to a platform at a height 0.5 m for 5 min. | ? | Kinematics: | |
Avg: average; B: break; BM: body mass; BMI: body mass index; COM: center of mass; CoP: center of pressure; EC: energy consumption; EMG: electromyography; EER: energy expenditure rate; F: female; f: frequency; G1: group 1; G2: group 2; HC: high-cam (supporting predominantly at trunk bending angles from 0−20 degrees); HR: heart rate; LBP: low back pain; LC: low-cam: (supporting predominantly at trunk bending angles >20 degrees); LS: level of symmetry; LT: lifting trial; M: male; MFI: mean fatigue index; min: minute; NMC: net metabolic cost; NMCL: net metabolic cost of lifting; NMCW: net metabolic cost of walking; : normalized heart rate; PCEE: percentage changes in energy expenditure; PWS: preferred walking speed without the exoskeleton; PWSX: preferred walking speed with the exoskeleton; RMS: root mean square; ROM: range of motion; RR: respiratory rate; s: second; SST: static stooping bending; T1: task 1; T2: task 2; : carbon dioxide production rate; : oxygen consumption rate; WT: walking test; WE: with exoskeleton; WEC: with exoskeleton condition; WOE: without exoskeleton; WOEC: without exoskeleton condition; y: years; (1): data not reported; ?: not specified.
Figure 2The risk of bias summary: authors’ judgements for each included study and for each considered domain.
Figure 3The risk of bias graph: authors’ judgements for each risk of bias reported as percentages across the different studies included in the review.
Description of all the outcome parameters from the eligible studies.
| Outcome Measure | Unit | Description and/or Calculation | Reference |
|---|---|---|---|
| EER | Kcal/min*kg | Energy expenditure rate estimated using the Brockway equation (1987) [ | Alemi et al. 2020 [ |
| PCEE | % | Percentage changes in energy expenditure considering WEC vs. WOEC. | |
|
| ml/min*kg | Oxygen consumption rate at rest, mean value over the last minute before starting T1 or T2, normalized with respect to the body mass. | Schmalz et al. 2019 [ |
|
| ml/min*kg | Oxygen consumption rate of T1, mean value over the last minute of the task, normalized with respect to the body mass. | |
|
| ml/min*kg | Oxygen consumption rate of T2, mean value over the last minute of the task, normalized with respect to the body mass. | |
|
| beat/min | Heart rate at rest, mean value over the last minute before starting T1 or T2. | |
|
| beat/min | Heart rate of T1, mean value over the last minute of the task. | |
|
| beat/min | Heart rate of T2, mean value over the last minute of the task. | |
|
| W/kg | Net metabolic cost was calculated by subtracting the resting metabolic cost from the total metabolic rate during lifting from knee height with Laevo LC. The metabolic cost of lifting was estimated using the Garby and Astrup equation [ | Baltrush et al. (2019) [ |
|
| % | Percentage of reduction in metabolic cost between WEC and WOEC for lifting from knee height, with the Laevo LC. | |
|
| W/kg | Net metabolic cost was calculated by subtracting the resting metabolic cost from the total metabolic rate during lifting from knee height with Laevo HC. The metabolic cost of lifting was estimated using the Garby and Astrup equation [ | |
|
| % | Percentage of reduction in metabolic cost between WEC and WOEC for lifting from knee height with the Laevo HC. | |
|
| W/kg | Net metabolic cost was calculated by subtracting the resting metabolic cost from the total metabolic rate during lifting from ankle height with the Laevo LC. The metabolic cost of lifting was estimated using the Garby and Astrup equation [ | |
|
| % | Percentage of reduction in metabolic cost between WEC and WOEC for lifting from ankle height with the Laevo LC. | |
|
| W/kg | Net metabolic cost was calculated by subtracting the resting metabolic cost from the total metabolic rate during lifting from ankle height with the Laevo HC. The metabolic cost of lifting was estimated using the Garby and Astrup equation [ | |
|
| % | Percentage of reduction in metabolic cost between WEC and WOEC for lifting from ankle height with the Laevo HC. | |
|
| J/m*kg | The metabolic cost of walking with and without Laevo LC at PSW was estimated using the Garby and Astrup equation [ | |
|
| J/m*kg | The metabolic cost of walking with and without the Laevo LC at PSWX was estimated using the Garby and Astrup equation [ | |
|
| ml/kg*min | Average oxygen consumption, normalized by weight. | Whitfield et al. (2014) [ |
|
| Beat/min | Heart rate. | |
|
| W/kg | Net metabolic cost was calculated by subtracting the resting metabolic cost from the total metabolic rate during lifting. The total metabolic cost of lifting from ankle to hip height with SPEXOR was estimated using the Garby and Astrup equation [ | Baltrush et al. (2020) [ |
|
| % | Percentage of reduction in metabolic cost between WEC and WOEC for lifting. | |
|
| Kcal/min*kg | Median metabolic cost of energy (1) during static holding posture normalized by weight. | Wei et al., (2020a) [ |
| RR | l/min | Respiratory rate collected before and after wearing the exoskeleton. | Han et al. (2019) [ |
|
| beat/min | Average heart rate before wearing the exoskeleton. | |
|
| beat/min | Average heart rate after wearing the exoskeleton. | |
|
| ml/kg*min | Average oxygen consumption, normalized by weight. | Maurice et al. (2020) [ |
|
| Average heart rate normalized using the maximum and minimum values of the participant in WOEC. | ||
|
| Kcal/min*Kg | Metabolic rate for 5 min during continuous manual material handling, normalized by weight. | Wei et al. (2020b) [ |
| EC | Kcal | Energy consumption for 5 min during continuous manual material handling. |
LC: low-cam (supporting predominantly at trunk bending angles >20 degrees); HC: high-cam (supporting predominantly at trunk bending angles from 0 to 20 degrees); l: liter; min: minute; ml: milliliter; kcal: kilocalories; kg: kilogram; J: joule; PWS: preferred walking speed without the exoskeleton; PWSX: preferred walking speed with the exoskeleton; T1: task 1; T2: task 2; W: watt; (1): it is not specified how the metabolic cost was calculated.
The values of the outcome parameters of interest reported in the selected studies.
| Exoskeleton Condition | Control Condition | ||||||
|---|---|---|---|---|---|---|---|
| Ref. | Outcome | Subject | Exoskeleton | Task | M (SD) | Task | M (SD) |
| Alemi et al. (2020) [ | EER | 18 | Laevo | All trials | 0.07 (0.02) (*) | All trials | 0.075 (0.019) |
| SuitX | 0.068 (0.018) (*) | ||||||
| PCEE (%) | Laevo | All trials | −7.5 | ||||
| SuitX | −8 | ||||||
| Laevo | KA | −5.3 | |||||
| KS | −10.8 | ||||||
| SA | −5.5 | ||||||
| SS | −8.9 | ||||||
| SuitX | KA | −6.2 | |||||
| KS | −9.1 | ||||||
| SA | −3.7 | ||||||
| SS | −12.6 | ||||||
| Schmalz et al. (2019) [ | 12 | Paexo | rest | 4.1 (2) | rest | 3.9 (2) | |
| T1 | 5.2 (2) (*) | T1 | 5.8 (2) | ||||
| T2 | 6.6 (2) (*) | T2 | 7.4 (2) | ||||
| rest | 75 (2) | rest | 74 (2) | ||||
| T1 | 98 (2) (*) | T1 | 103 (2) | ||||
| T2 | 93 (2) (*) | T2 | 99 (2) | ||||
| Baltrush et al. (2019) [ | 11 M | Laevo LC | LT- knee height | 7 | LT- knee height | 3.09 (0.92) | |
| Laevo HC | 2.56 (0.52) (*) | ||||||
| Laevo LC | LT- ankle height | 8 | LT-ankle height | 5.06 (1.11) | |||
| Laevo HC | 4.27 (0.6) (*) | ||||||
| 13 M | Laevo LC | WT-PSW | (1) | WT-PSW | (1) | ||
| Laevo LC | WT-PSWX | (1) | WT-PSWX | (1) | |||
| Whitfield et al. (2014) [ | 15 M | PLAD | LT | 17.7 (2.6) | LT | 17.9 (2.4) | |
| Baltrush et al. (2019) [ | 10 M | SPEXOR | LT | 4.64 (1.38) (*) | LT | 5.63 (1.26) | |
| Wei et al. (2020a) [ | 8 M | MeBot-EXO | Static holding posture | (2) (*) | Forward torso flexion | (2) | |
| Han et al. (2019) [ | RR | 3 subjects | Passive energy-storing booster exoskeleton | LT | 16 | 25 | |
| 94 (*) | 114 (*) | ||||||
| Maurice et al. (2020) [ | 12 M | PAEXO | Overhead pointing task | (2) (*) | Overhead pointing task | (2) (*) | |
|
| (2) (*) | (2) (*) | |||||
| Wei et al. (2020b) [ |
| 3 M | MeBot-EXO | LT | (2) (*) |
| (2) (*) |
| EC | 17.9 | 22.9 | |||||
LC: low-cam: (supporting predominantly at trunk bending angles >20 degrees); HC: high-cam (supporting predominantly at trunk bending angles from 0 to 20 degrees); EER: energy expenditure rate: F: female; : average heart rate; : average heart rate normalized using the maximum and minimum values of the participant in WOEC; KA: kneeling posture, asymmetric lifting/lowering; KS: kneeling posture, symmetric lifting/lowering; M: male; NW: no exoskeleton; NMC: net metabolic cost; : net metabolic cost during lifting from ankle with the Laevo LC; : net metabolic cost during lifting from ankle with the Laevo HC; : net metabolic cost during lifting from knee with the Laevo LC; : net metabolic cost during lifting from knee with the Laevo HC; PCEE: percentage changes in energy expenditure; : percentage of reduction in metabolic cost between WEC and WOEC for lifting; : percentage of reduction in metabolic cost between WEC and WOEC for lifting from ankle height with the Laevo LC; : percentage of reduction in metabolic cost between WEC and WOEC for lifting from ankle height with the Laevo HC; : percentage of reduction in metabolic cost between WEC and WOEC for lifting from knee height with the Laevo LC; : percentage of reduction in metabolic cost between WEC and WOEC for lifting from knee height with the Laevo HC; PWS: preferred walking speed without the exoskeleton; PWSX: preferred walking speed with the exoskeleton; RR: respiration rate; SA: standing posture, asymmetric lifting/lowering; SS: standing posture, symmetric lifting/lowering; : average oxygen consumption, normalized by weight; WE: with exoskeleton; WT: walking test; (1): value not reported, relation deduced from Figure 7 in [42]; (2): data not explicitly reported that should be approximately quantified from the figure; (*): significant differences from WOE.